All Journals > Clinical Infectious Diseases > 1 June 2008 > Paratyphoid Fever in the United States

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

1 June 2008

Volume 46, Number 11
Clinical Infectious Diseases 2008;46:1656–1663
1058-4838/2008/4611-0003
DOI: 10.1086/587894
MAJOR ARTICLE

Laboratory‐Based Surveillance of Paratyphoid Fever in the United States: Travel and Antimicrobial Resistance

Sundeep K. Gupta,

Felicita Medalla,

Michael W. Omondi,

Jean M. Whichard,

Patricia I. Fields,

Peter Gerner‐Smidt,

Nehal J. Patel,

Kara L. F. Cooper,

Tom M. Chiller, and

Eric D. Mintz

Division of Foodborne, Bacterial, and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Background.The incidence of paratyphoid fever, including paratyphoid fever caused by antimicrobial‐resistant strains, is increasing globally. However, the epidemiologic and laboratory characteristics of paratyphoid fever in the United States have never been studied.

Methods.We attempted to interview all patients who had been infected with laboratory‐confirmed Salmonella serotypes Paratyphi A, Paratyphi B, or Paratyphi C in the United States with specimens collected from 1 April 2005 through 31 March 2006. At the Centers for Disease Control and Prevention (CDC), isolates underwent serotype confirmation, antimicrobial susceptibility testing, and pulsed‐field gel electrophoresis typing.

Results.Of 149 patients infected with Salmonella Paratyphi A, we obtained epidemiologic information for 89 (60%); 55 (62%) of 86 were hospitalized. Eighty‐five patients (96%) reported having travel internationally, and 80 (90%) had traveled to South Asia. Of the 146 isolates received at the CDC, 127 (87%) were nalidixic acid resistant; nalidixic acid resistance was associated with travel to South Asia (odds ratio, 17.0; 95% confidence interval, 3.8–75.9). All nalidixic acid–resistant isolates showed decreased susceptibility to ciprofloxacin (minimum inhibitory concentration, 0.12 μg/mL). Of 49 patients infected with Salmonella Paratyphi B, only 12 (24%) were confirmed to have Paratyphi B when tested at the CDC. Four (67%) of 6 patients were hospitalized, and 5 (83%) reported travel (4 to the Andean region of South America). One case of Salmonella Paratyphi C infection was reported in a traveler to West Africa with a urinary tract infection.

Conclusions.Physicians should be aware of the increasing incidence of infection due to Salmonella Paratyphi A and treatment options given its widespread antimicrobial resistance. A paratyphoid fever vaccine is urgently needed. Continued surveillance for paratyphoid fever will help guide future prevention and treatment recommendations.

Received 19 November 2007; accepted 14 January 2008; electronically published 18 April 2008.

Reprints or correspondence: Dr. Sundeep K. Gupta, 2190 Kampala Place, Dulles, VA 20189 ().

Cited by

David K. Byers, Kyle Petersen. (2009) A Case of Salmonella enterica Serotype Typhi in a Patient Without a History of International Travel. Journal of Travel Medicine 16:3, 223-225
Online publication date: 1-Jun-2009.
CrossRef
S. Hume, T. Schulz, P. Vinton, T. Korman, J. Torresi. (2009) Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience. European Journal of Clinical Microbiology & Infectious Diseases
Online publication date: 9-May-2009.
CrossRef
Christopher M Parry, EJ Threlfall. (2008) Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Current Opinion in Infectious Diseases 21:5, 531-538
Online publication date: 1-Nov-2008.
CrossRef
Close Popup